Molecular subtyping of paediatric medulloblastoma by immunohistochemistry

Four core molecular subgroups of medulloblastomas have recently been introduced disparate by their transcriptional profile, all of which have different prognostic value. We aimed to determine the histological variants and molecular subtypes of medulloblastomas by immunohistochemistry in our po...

Full description

Bibliographic Details
Main Authors: Wong, Yin Ping, Loh, C-Khai, Hamidah Alias, Nur Maya Sabrina T, Muaatamarulain M, Tan, Geok Chin
Format: Article
Language:English
Published: Pusat Perubatan Universiti Kebangsaan Malaysia 2020
Online Access:http://journalarticle.ukm.my/16275/
http://journalarticle.ukm.my/16275/1/13_ms0428_pdf_38169.pdf
_version_ 1848814011226783744
author Wong, Yin Ping
Loh, C-Khai
Hamidah Alias,
Nur Maya Sabrina T,
Muaatamarulain M,
Tan, Geok Chin
author_facet Wong, Yin Ping
Loh, C-Khai
Hamidah Alias,
Nur Maya Sabrina T,
Muaatamarulain M,
Tan, Geok Chin
author_sort Wong, Yin Ping
building UKM Institutional Repository
collection Online Access
description Four core molecular subgroups of medulloblastomas have recently been introduced disparate by their transcriptional profile, all of which have different prognostic value. We aimed to determine the histological variants and molecular subtypes of medulloblastomas by immunohistochemistry in our population, and to correlate that with clinicopathological parameters. Seventeen patients aged four-month to 14.3 years diagnosed with medulloblastoma were recruited from year 2002 to 2017. All medulloblastomas were assigned to various histological variants and molecular subgroups by immunohistochemistry surrogate markers (YAP-1 and beta catenin). They were then correlated with clinicopathological parameters and outcomes. Classic histology (76.5%) was the commonest, followed by large cell/anaplastic (LCA) (17.6%) and desmoplastic/nodular (DN) variants (59%). The most frequent molecular subgroup was non-SHH/WNT tumours (64.7%), seconded by SHH tumours (35.3%). Among the SHH tumours, 66.7% was classic histology and the remaining 33.3% was LCA variant. Interestingly, one DN histology demonstrated YAP-1 and beta catenin immunonegativity, denoting non-SHH/WNT molecular subgroup. Majority (88.2%) medulloblastomas were at midline 4th ventricle location, including DN variant. Estimated three-year disease�free-survival (DFS) and overall-survival (OS) was 60% and 86.7%, respectively. Age <3 years at diagnosis, tumour size >5 cm, LCA histology and high risk group were inversely correlated with DFS, with early relapse. Infant <3-year-old had worse OS. Other factors had no significant impact on DFS and OS. We had demonstrated the feasibility of simple immunohistochemistry-based surrogate markers (YAP-1 and beta catenin) to stratify medulloblastomas into distinct molecular subtypes. Prognostic and predictive values of YAP-1 immunomarker in medulloblastomas however await further investigations.
first_indexed 2025-11-15T00:27:18Z
format Article
id oai:generic.eprints.org:16275
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T00:27:18Z
publishDate 2020
publisher Pusat Perubatan Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:162752021-03-16T02:53:49Z http://journalarticle.ukm.my/16275/ Molecular subtyping of paediatric medulloblastoma by immunohistochemistry Wong, Yin Ping Loh, C-Khai Hamidah Alias, Nur Maya Sabrina T, Muaatamarulain M, Tan, Geok Chin Four core molecular subgroups of medulloblastomas have recently been introduced disparate by their transcriptional profile, all of which have different prognostic value. We aimed to determine the histological variants and molecular subtypes of medulloblastomas by immunohistochemistry in our population, and to correlate that with clinicopathological parameters. Seventeen patients aged four-month to 14.3 years diagnosed with medulloblastoma were recruited from year 2002 to 2017. All medulloblastomas were assigned to various histological variants and molecular subgroups by immunohistochemistry surrogate markers (YAP-1 and beta catenin). They were then correlated with clinicopathological parameters and outcomes. Classic histology (76.5%) was the commonest, followed by large cell/anaplastic (LCA) (17.6%) and desmoplastic/nodular (DN) variants (59%). The most frequent molecular subgroup was non-SHH/WNT tumours (64.7%), seconded by SHH tumours (35.3%). Among the SHH tumours, 66.7% was classic histology and the remaining 33.3% was LCA variant. Interestingly, one DN histology demonstrated YAP-1 and beta catenin immunonegativity, denoting non-SHH/WNT molecular subgroup. Majority (88.2%) medulloblastomas were at midline 4th ventricle location, including DN variant. Estimated three-year disease�free-survival (DFS) and overall-survival (OS) was 60% and 86.7%, respectively. Age <3 years at diagnosis, tumour size >5 cm, LCA histology and high risk group were inversely correlated with DFS, with early relapse. Infant <3-year-old had worse OS. Other factors had no significant impact on DFS and OS. We had demonstrated the feasibility of simple immunohistochemistry-based surrogate markers (YAP-1 and beta catenin) to stratify medulloblastomas into distinct molecular subtypes. Prognostic and predictive values of YAP-1 immunomarker in medulloblastomas however await further investigations. Pusat Perubatan Universiti Kebangsaan Malaysia 2020-12 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/16275/1/13_ms0428_pdf_38169.pdf Wong, Yin Ping and Loh, C-Khai and Hamidah Alias, and Nur Maya Sabrina T, and Muaatamarulain M, and Tan, Geok Chin (2020) Molecular subtyping of paediatric medulloblastoma by immunohistochemistry. Medicine & Health, 15 (2). pp. 124-139. ISSN 2289-5728 https://www.medicineandhealthukm.com/toc/15/2
spellingShingle Wong, Yin Ping
Loh, C-Khai
Hamidah Alias,
Nur Maya Sabrina T,
Muaatamarulain M,
Tan, Geok Chin
Molecular subtyping of paediatric medulloblastoma by immunohistochemistry
title Molecular subtyping of paediatric medulloblastoma by immunohistochemistry
title_full Molecular subtyping of paediatric medulloblastoma by immunohistochemistry
title_fullStr Molecular subtyping of paediatric medulloblastoma by immunohistochemistry
title_full_unstemmed Molecular subtyping of paediatric medulloblastoma by immunohistochemistry
title_short Molecular subtyping of paediatric medulloblastoma by immunohistochemistry
title_sort molecular subtyping of paediatric medulloblastoma by immunohistochemistry
url http://journalarticle.ukm.my/16275/
http://journalarticle.ukm.my/16275/
http://journalarticle.ukm.my/16275/1/13_ms0428_pdf_38169.pdf